久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/06/24 | 3,677 | 3,718 | 3,655 | 3,704 | +68 | +1.9% | 137,100 |
2024/06/21 | 3,661 | 3,683 | 3,629 | 3,636 | -28 | -0.8% | 424,000 |
2024/06/20 | 3,651 | 3,686 | 3,641 | 3,664 | -6 | -0.2% | 94,300 |
2024/06/19 | 3,650 | 3,676 | 3,641 | 3,670 | -6 | -0.2% | 88,500 |
2024/06/18 | 3,733 | 3,747 | 3,657 | 3,676 | -52 | -1.4% | 136,600 |
2024/06/17 | 3,736 | 3,742 | 3,700 | 3,728 | -16 | -0.4% | 92,100 |
2024/06/14 | 3,700 | 3,767 | 3,700 | 3,744 | +6 | +0.2% | 179,900 |
2024/06/13 | 3,755 | 3,765 | 3,720 | 3,738 | -26 | -0.7% | 77,000 |
2024/06/12 | 3,764 | 3,791 | 3,758 | 3,764 | -5 | -0.1% | 64,700 |
2024/06/11 | 3,833 | 3,840 | 3,769 | 3,769 | -51 | -1.3% | 72,200 |
2024/06/10 | 3,788 | 3,826 | 3,779 | 3,820 | +24 | +0.6% | 123,200 |
2024/06/07 | 3,766 | 3,797 | 3,752 | 3,796 | +20 | +0.5% | 79,300 |
2024/06/06 | 3,820 | 3,820 | 3,751 | 3,776 | -10 | -0.3% | 63,100 |
2024/06/05 | 3,796 | 3,806 | 3,769 | 3,786 | -18 | -0.5% | 78,300 |
2024/06/04 | 3,760 | 3,828 | 3,757 | 3,804 | +38 | +1% | 126,100 |
2024/06/03 | 3,767 | 3,779 | 3,748 | 3,766 | +30 | +0.8% | 100,700 |
2024/05/31 | 3,682 | 3,741 | 3,682 | 3,736 | +74 | +2% | 301,000 |
2024/05/30 | 3,650 | 3,666 | 3,600 | 3,662 | -10 | -0.3% | 127,000 |
2024/05/29 | 3,700 | 3,710 | 3,665 | 3,672 | -33 | -0.9% | 110,000 |
2024/05/28 | 3,711 | 3,738 | 3,705 | 3,705 | -36 | -1% | 85,600 |
2024/05/27 | 3,738 | 3,746 | 3,699 | 3,741 | +6 | +0.2% | 119,400 |
2024/05/24 | 3,742 | 3,777 | 3,705 | 3,735 | +26 | +0.7% | 205,500 |
2024/05/23 | 3,705 | 3,722 | 3,696 | 3,709 | ±0 | ±0% | 103,600 |
2024/05/22 | 3,750 | 3,768 | 3,697 | 3,709 | -41 | -1.1% | 160,700 |
2024/05/21 | 3,809 | 3,815 | 3,750 | 3,750 | -59 | -1.5% | 147,800 |
2024/05/20 | 3,795 | 3,835 | 3,794 | 3,809 | +13 | +0.3% | 86,300 |
2024/05/17 | 3,792 | 3,817 | 3,768 | 3,796 | ±0 | ±0% | 93,100 |
2024/05/16 | 3,774 | 3,803 | 3,766 | 3,796 | +22 | +0.6% | 132,700 |
2024/05/15 | 3,790 | 3,804 | 3,761 | 3,774 | -21 | -0.6% | 79,600 |
2024/05/14 | 3,785 | 3,816 | 3,785 | 3,795 | +2 | +0.1% | 65,900 |
2024/05/13 | 3,805 | 3,816 | 3,776 | 3,793 | -30 | -0.8% | 81,400 |
2024/05/10 | 3,840 | 3,854 | 3,805 | 3,823 | -12 | -0.3% | 120,900 |
2024/05/09 | 3,800 | 3,874 | 3,779 | 3,835 | +57 | +1.5% | 187,800 |
2024/05/08 | 3,783 | 3,792 | 3,738 | 3,778 | +12 | +0.3% | 134,500 |
2024/05/07 | 3,741 | 3,769 | 3,721 | 3,766 | +26 | +0.7% | 212,600 |
2024/05/02 | 3,850 | 3,858 | 3,729 | 3,740 | -79 | -2.1% | 323,000 |
2024/05/01 | 3,820 | 3,835 | 3,798 | 3,819 | -4 | -0.1% | 143,600 |
2024/04/30 | 3,798 | 3,824 | 3,769 | 3,823 | +44 | +1.2% | 111,900 |
2024/04/26 | 3,740 | 3,779 | 3,688 | 3,779 | +69 | +1.9% | 224,600 |
2024/04/25 | 3,734 | 3,736 | 3,701 | 3,710 | -38 | -1% | 203,900 |
2024/04/24 | 3,788 | 3,792 | 3,740 | 3,748 | -32 | -0.8% | 122,000 |
2024/04/23 | 3,790 | 3,799 | 3,762 | 3,780 | +6 | +0.2% | 101,800 |
2024/04/22 | 3,732 | 3,781 | 3,720 | 3,774 | +55 | +1.5% | 172,700 |
2024/04/19 | 3,738 | 3,753 | 3,695 | 3,719 | -19 | -0.5% | 170,500 |
2024/04/18 | 3,745 | 3,791 | 3,714 | 3,738 | +13 | +0.3% | 196,300 |
2024/04/17 | 3,800 | 3,800 | 3,708 | 3,725 | -75 | -2% | 164,500 |
2024/04/16 | 3,794 | 3,819 | 3,766 | 3,800 | -25 | -0.7% | 200,300 |
2024/04/15 | 3,909 | 3,930 | 3,784 | 3,825 | -84 | -2.1% | 304,500 |
2024/04/12 | 3,868 | 3,927 | 3,792 | 3,909 | -29 | -0.7% | 311,400 |
2024/04/11 | 3,932 | 3,969 | 3,901 | 3,938 | -17 | -0.4% | 162,300 |
201~
250
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 448,600円 | +5.8% | +1.2% | 2.67% | 14.88倍 | 1.18倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 232,600円 | +18.2% | +4.2% | 1.55% | 16.33倍 | 2.08倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 140,800円 | 0.0% | +50.6% | 2.56% | 14.79倍 | 1.66倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ツムラ | 440,000円 | +20.9% | +87.3% | 3.09% | 9.83倍 | 1.13倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
住友ファーマ | 70,800円 | +21.1% | - | 0.00% | 17.58倍 | 2.46倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム